Haya Therapeutics Announces Funding From Swiss Innovation Agency Supporting Research Collaborations For Long Non-Coding Rna Therapies
Round Type
Funding Round
LausanneBiotechnologyHealth CareScience And EngineeringDescription
HAYA Therapeutics, SA, a company developing precision medicines that target tissue and cell-specific long non-coding RNAs (lncRNAs), today announced that Innosuisse, the Swiss Innovation Agency, is supporting two research collaboration projects between HAYA and the University of Bern, University Hospital of Bern and Lausanne University Hospital. Innosuisse is funding 50 percent of the total project costs of approximately CHF 3.1 million (US$3.3 million).
Quick answer
Haya Therapeutics raised an undisclosed amount in a Funding Round round, dated May 3, 2022. Haya Therapeutics is based in Lausanne, Vaud, Switzerland.
- How much did Haya Therapeutics raise?
- Haya Therapeutics raised an undisclosed amount in a Funding Round round on May 3, 2022.
- What does Haya Therapeutics do?
- HAYA Therapeutics is a precision medicines company developing programmable therapeutics targeting regulatory RNAs derived from the dark genome, a cell information processing unit, to reprogram pathological cell states..
- Where is Haya Therapeutics based and how big is it?
- Haya Therapeutics is based in Lausanne, Vaud, Switzerland.
- Who are the decision-makers at Haya Therapeutics?
- Fundz holds 1 contact at Haya Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Haya Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- PineTree Therapeutics raised $24M (Series A) on June 7, 2022.
- Upstream Bio raised $200M (Series A) on June 2, 2022.
- 22nd Century raised $58M on May 25, 2022.
- OliX Pharmaceuticals raised $45M (Funding Round) on May 25, 2022.
- Vyriad raised $30M (Series B) on May 17, 2022.
- Moma Therapeutics raised $150M (Series B) on May 10, 2022.
Who to call at Haya Therapeutics, and when
A new round usually means Haya Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Haya Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Haya Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Haya Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Haya Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Haya Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.